Role of the classical and terminal complement activation pathways in CAD and targets of complement inhibitors. Only relevant details are shown. Black arrow, major pathway; gray/dotted arrow, minor pathway; C1-INH, plasma-derived C1 esterase inhibitor; MAC, membrane attack complex.